Harvard Business Review
OCTOBER 26, 2011
Between 2006 and 2008, more than $1 billion venture-capital dollars were channeled into startups focused on solar, wind and biofuel technologies. A star example is Google, which raised a mere $40 million in private funding before its IPO at a $23 billion valuation.
Harvard Business Review
FEBRUARY 22, 2013
Cephalon's IPO was in 1991, part of the second wave of biotechnology companies to sell shares to the public. From a failed product to a stock that rose to a value of over $5 billion in much of the 2006-2010 period, Frank Baldino had rebuilt a decimated company, creating meaningful wealth for his shareholders and many of his employees.
Expert insights. Personalized for you.
11 
Let's personalize your content